S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
UK
LSE
Medivir Ab (0GP7)
Medivir Ab (0GP7) News

0GP7

Medivir Ab (0GP7)

Medivir Ab

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0GP7

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
01/15/2024	1:45AM	PR Newswire (US)	Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox	LSE:0GP7	Medivir Ab
01/04/2024	1:47AM	PR Newswire (US)	Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study	LSE:0GP7	Medivir Ab
12/19/2023	1:54AM	PR Newswire (US)	Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan	LSE:0GP7	Medivir Ab
12/13/2023	4:12AM	PR Newswire (US)	Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval	LSE:0GP7	Medivir Ab
12/06/2023	5:20AM	PR Newswire (US)	Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway	LSE:0GP7	Medivir Ab
12/06/2023	1:44AM	PR Newswire (US)	Medivir to present at the Carlsquare Equity Research Investor Day	LSE:0GP7	Medivir Ab
12/01/2023	4:32AM	PR Newswire (US)	Bulletin from Extraordinary General Meeting in Medivir AB (publ)	LSE:0GP7	Medivir Ab
11/27/2023	2:52AM	PR Newswire (US)	Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC	LSE:0GP7	Medivir Ab
11/22/2023	1:46AM	PR Newswire (US)	Medivir to present at the Redeye Life Science Day	LSE:0GP7	Medivir Ab
11/21/2023	1:48AM	PR Newswire (US)	Medivir to present at the Erik Penser Bank Company Event	LSE:0GP7	Medivir Ab
11/13/2023	2:49AM	PR Newswire (US)	Medivir to present clinical data at ASCO-GI with fostrox + Lenvima in HCC and shares positive response from Type D meeting with FDA	LSE:0GP7	Medivir Ab
11/07/2023	2:50PM	PR Newswire (US)	Notice of Extraordinary General Meeting in Medivir AB (publ)	LSE:0GP7	Medivir Ab
10/27/2023	2:01AM	PR Newswire (US)	MEDIVIR AB - INTERIM REPORT JANUARY - SEPTEMBER 2023	LSE:0GP7	Medivir Ab
10/25/2023	1:46AM	PR Newswire (US)	Medivir to report new and updated data from ongoing phase 2a HCC study as part of its Q3 report on Friday	LSE:0GP7	Medivir Ab
10/23/2023	1:48AM	PR Newswire (US)	Nomination Committee of Medivir appointed	LSE:0GP7	Medivir Ab
10/20/2023	8:29AM	PR Newswire (US)	Change in Medivir's Board of Directors	LSE:0GP7	Medivir Ab
05/16/2023	11:38AM	PR Newswire (US)	Issue, repurchase and reclassification of shares of series C and transfer of ordinary shares under LTIP 2023	LSE:0GP7	Medivir Ab
05/04/2023	9:55AM	PR Newswire (US)	Execution of the annual general meeting's resolution on the removal of share class in Medivir AB (publ)	LSE:0GP7	Medivir Ab
05/04/2023	9:25AM	PR Newswire (US)	Resolutions at the Annual General Meeting in Medivir on 4 May 2023	LSE:0GP7	Medivir Ab
04/27/2023	2:06AM	PR Newswire (US)	MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2023	LSE:0GP7	Medivir Ab
04/17/2023	2:30AM	PR Newswire (US)	Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination	LSE:0GP7	Medivir Ab
04/04/2023	4:03AM	PR Newswire (US)	Medivir 2022 Annual Report published	LSE:0GP7	Medivir Ab
03/31/2023	5:25AM	PR Newswire (US)	Notice of Annual General Meeting of Medivir AB (publ)	LSE:0GP7	Medivir Ab
03/17/2023	3:01AM	PR Newswire (US)	Medivir to present data on additive efficacy of fostrox in triple combination with anti-PD1 and kinase inhibitor in nonclinical tumor models at AACR	LSE:0GP7	Medivir Ab
03/14/2023	3:18AM	PR Newswire (US)	First patient dosed in the phase 2a part of Medivir's study with fostrox in combination with Lenvima®	LSE:0GP7	Medivir Ab
03/08/2023	9:08AM	PR Newswire (US)	Medivir to present at the Stockholm Corporate Finance Life Science Day	LSE:0GP7	Medivir Ab
02/23/2023	2:03AM	PR Newswire (US)	Medivir to present at the Erik Penser Bank Healthcare Day	LSE:0GP7	Medivir Ab
02/21/2023	2:54AM	PR Newswire (US)	Pia Baumann takes up her position as Chief Medical Officer	LSE:0GP7	Medivir Ab
02/20/2023	4:04AM	PR Newswire (US)	Medivir has determined the recommended phase 2 dose for fostrox in combination with Lenvima in HCC	LSE:0GP7	Medivir Ab
02/15/2023	2:15AM	PR Newswire (US)	MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2022	LSE:0GP7	Medivir Ab

Showing the most relevant articles for your search:LSE:0GP7

1 2 3 4 Next >>

Intergrated Cannabis Sol... (PK)

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Kraig Biocraft Laborator... (QB)

Lightwave Logic

Asia Broadband (PK)

Fannie Mae (QB)

North Bay Resources (PK)

Northwest Biotherapeutics (QB)

Anavex Life Sciences

Code Green Apparel (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions